Hemostatic Gels Market
Market Insights on Hemostatic Gels covering sales outlook, demand forecast & up-to-date key trends
Hemostatic Gels Market By Material, Indication, End User & Region - Forecast 2022 – 2032
Hemostatic Gels Market Outlook (2022-2032)
[300 Pages Report] The global hemostatic gels market was valued at US$ 957.1 Mn in 2021, and is expected to expand at a CAGR of 6.8% to reach US$ 1.9 Bn by 2032. According to a recent study by Future Market Insights, porcine-based hemostatic gels are leading the market with a market share of about 45% in 2021 among the material types.
|
Data Points |
Market Insights |
|
Hemostatic Gels Market Base Year Value (2021) |
US$ 957.1 Mn |
|
Estimated Market Size (2022) |
US$ 1.0 Bn |
|
Projected Market Valuation (2032) |
US$ 1.9 Bn |
|
Value-based CAGR (2022-2032) |
6.8% |
|
Market Share of Top 5 Countries |
45.9% |
Hemostatic gel is used as an assistant or alternative to hemostat devices to manage bleeding or wound closure. Blood loss is one of the main causes of death in physical trauma. It is important to manage blood loss and achieve quicker clotting than the natural clotting process which is occurred in the body. To achieve blood clotting more quickly, physicians occasionally use hemostatic agents such as a hemostatic gel. These gels may promote clotting and thereby stop or control bleeding.
Let us know your requirement to get
100% FREE customization
2017-2021 Hemostatic Gels Market Historic Outlook Vs 2022 to 2032 Forecast
The market value for hemostatic gels was approximately 21.8% of the overall US$ 4.3 Bn of the global hemostats market in 2021. Sales of hemostatic gels increased at a CAGR of 5.4% between 2017 to 2021, owing to the growing volume of surgical procedures.
Growing interest in developing new hemostatic agents is due to unmet needs in modifying uncontrolled hemorrhages in emergency care, surgical procedures, and frontline situations. Even though a wide range of hemostats are available, the development of ideal hemostatic agents such as hemostatic gel formulations that offer including the ability to successfully and instantly manage blood loss, excellent mechanical properties, biocompatibility, antibacterial effect, strong tissue adhesion properties, and biodegradability, under wet and active conditions, remains a challenge.
Benefiting from biocompatibility, high porosity, injectability, and ease of handling, polymeric hydrogels with outstanding hemostatic properties have been receiving consideration over the last decade. Furthermore, the development of novel technologies to cater to the demand for high-quality gel-forming hemostatic agents will drive the overall hemostatic gels market.
The market is projected to witness lucrative growth during forecast period owing to increasing volumes of surgical procedures. According to WHO, annually, a surprising 310 million major surgeries are performed globally; and in U.S. and Europe, approximately 45 and 20 million surgeries are carried out respectively every year. This is attributed to the growing prevalence of obesity and other lifestyle diseases, rising prevalence of orthopaedic disease, and the growing occurrence of spinal and sports-related injuries.
Moreover, in both developed and emerging countries the number of hospitals and surgical centers is growing. The demand for hemostats such as hemostatic gels is high in these newly established hospitals and surgical centers due to the growing patient population base.
For instance, in the last quarter of 2020, U.K. Prime Minister Boris Johnson declared an investment of US4 4.3 Bn for 40 hospitals and certain schemes for upcoming funding for 48 hospitals by 2030.
Also, Steward Health Care in March 2021 announced plans to construct a new hospital in Washington. Thus, owing to the above-mentioned factors, the global hemostatic gels market is expected to grow at a CAGR of 6.8% during the forecast period.
What are the Key Opportunities for Hemostatic Gels Manufacturers?
Hemostasis has high clinical importance in preventive, surgical, and emergency circumstances as blood loss may cause substantial diseases and deaths in civil and military individuals owing to bleeding problems rising from surgery, trauma injuries, and as hereditary, disease-related, or drug-induced blood syndromes.
For externally accessible injuries, a range of natural and synthetic biomaterials have to go through strong research, leading to hemostatic technologies including bandages, dressings, fibrin glues, tourniquets, tamponades, and hemostatic powders.
In contrast, treatment of internal non-compressible hemorrhage still severely relies on transfusion of pure blood or blood hemostatic components such as platelets, coagulation factors, and fibrinogens. Transfusion of platelets may experience significant challenges of high cost, limited availability, contamination risks, short shelf-life, performance variability, low portability, and immunological adverse reactions.
The usage of these blood hemostatic components provides only partial mechanisms for hemostasis. Through such concerns, interdisciplinary research is being conducted for the development of hemostatic gels that can be manufactured conveniently, and administered intravenously to mimic, leverage, and amplify physiological hemostatic mechanisms. This is expected to create opportunities for growth in the market for the development of effective and efficient hemostats.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-wise Insights
What is Driving the U.S. Hemostatic Gels Market?
“Increasing Incidence of Lifestyle Related Disorders is Driving Demand for Hemostatic Gels”
The U.S. dominated the North America hemostatic gels market, accounting for 82% of the total markets share in 2021. Rising prevalence of cardiovascular disorders, diabetes, and cancer in the U.S. is propelling the volume of surgical procedures, thereby necessitating hemostatic gels.
With the global rise in the incidence of chronic diseases, the volume of surgical procedures is expected to increase in the forthcoming years, which is expected to drive demand hemostatic gels for blood loss management.
According to the CDC, around 150 million Americans are suffering from at least one chronic condition, which leads to the need for surgery. With the growing incidence of chronic diseases, the number of injuries and surgeries is expected to increase, thereby increasing the usage of hemostatic gels in the U.S.
What is the India Hemostatic Gels Market Outlook?
“Rising Expenditure on Healthcare Infrastructure Will Augment Sales of Hemostatic Gels”
Demand for hemostatic gels in India is set to increase at a 7.4% CAGR over the assessment period. The market in India is driven by increasing demand for hemostatic gels due to growing government initiatives to create awareness about the product.
For instance, in November 2020, the transport department of the Rajasthan government mandated the addition of feracrylum, a hemostatic gel, in the first aid of all vehicles that are being registered from November 2020 following a direction of the high court. Feracrylum has been recognized to be a hemostatic agent by several clinical studies.
Why the U.K. Hemostatic Gels Market Considered Lucrative?
“Growing Trend of Medical Tourism in the U.K. Will Fuel the Adoption of Hemostatic Gels”
Sales in the U.K. market are projected to increase at a 7.1% CAGR over the forecast period. As per the British heart foundation (UK) and its heart and circulatory disease statistics, in 2019, there has been a substantial surge in the number of cardiac surgeries such as aortic valve replacement and angioplasty in the U.K.
Hemostatic gels have higher application in cardiovascular surgeries due to better clinical outcomes compared to other wound closure techniques. Thus, a growing number of cardiac surgeries is expected to spur demand for effective hemostatic gels in the U.K.
What Makes the China Hemostatic Gels Market Attractive?
“Increaisng Establishment of Hospitals and Ambulatory Centers in China Will Propel Demand for Hemostatic Gels”
China held approximately 38.0% of the East Asia hemostatic gels market in 2021. As per the report, sales are forecast to grow at a 8.0% CAGR through 2032.
The government in China is investing heavily in the construction of healthcare infrastructure such as hospitals and clinics. As per an article published in 2020, China announced an investment of US$ 4.6 Bn for the construction of hospitals in Wuhan.
There are now about 26,000 hospitals in China, more than in any other country; among them 60% are public and 40% are in the private sector. The significant growth in the number of hospitals and surgical centers is expected to boost sales of hemostatic gels.
Category-wise Insights
Which Hemostatic Gel Product Is Driving the Market?
“Sales of Porcine-based Hemostatic Gels to Gain Traction”
Based on product type, the porcine-based hemostatic gels segment held the highest market share of about 45% in 2021. As per the report, demand in the segment is expected to increase at a CAGR of 5.7% by the end of the forecast period. Ease of application, efficacy, biocompatibility, and cost-effectiveness are some of the key benefits offered by porcine-based hemostatic gels.
Which Indication Will Hold a Dominant Share in the Global Hemostatic Gels Market?
“Adoption of Hemostatic Gels for Cardiovascular Surgeries Will Increase”
In terms of indication, demand for hemostatic gels for cardiovascular surgeries will account for 33.1% of the total market share by 2032. Blood loss is one of the most common obstacle in cardiac surgeries, particularly following aortic involvements which leads to extended operating times, increased bleeding, and a higher risk of postoperative morbidity and mortality. The use of hemostatic gels, especially in patients undergoing cardiac surgical procedures, is safe and effective in reducing time to hemostasis, reducing transfusion of blood products, and improving patient outcomes.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Competitive Landscape
Leading players operating in the global hemostatic gels market are launching innovative products to meet the demand for a hemostatic gel that can be easily and specifically applied, particularly for irregular fractures where bandages can be difficult, and powders are messy and can cause uneasiness. For instance:
- In July 2021, Medcura, Inc., and ASO, LLC collaboratively launched Rapid-Seal, a high-performance, antibacterial hemostatic gel which is available on several e-commerce sites and the shelves at a leading U.S. drugstore chain.
- In December 2021, Cresilon, Inc. submitted a 510(k) premarket notification to the U.S. FDA for its registered hemostatic gel which is followed by the successful launch of Cresilon's VETIGEL, an innovative hemostatic gel for the veterinary use.
With several competitors in hemostatic gels manufacturing, the overall market is highly fragmented. To meet consumer demand and expand their customer base, these companies are implementing methods such as mergers and acquisitions, partnerships, and collaborations. For instance:
- In July 2021, Baxter International Inc. completed the acquisition of CryoLife, Inc. for certain assets related to PerClot, a polysaccharide hemostatic system for US$ 60.8 Mn.
Report Scope
|
Attribute |
Details |
|
Estimated Market Size (2022) |
US$ 1 Bn |
|
Projected Market Valuation (2032) |
US$ 1.9 Bn |
|
Value-based CAGR (2022-2032) |
6.8% |
|
Forecast Period |
2017-2021 |
|
Historical Data Available for |
2022-2032 |
|
Market Analysis |
US$ Bn for Value |
|
Key Regions Covered |
North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
|
Key Countries Covered |
The U.S., Canada, Brazil, Mexico, Argentina, the U.K., Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, and South Africa |
|
Key Market Segments Covered |
Material, Indication, End User, and Region |
|
Key Companies Profiled |
|
Key Market Segments Covered In Hemostatic Gels Industry Research
By Material:
- Bovine-Based
- Porcine-Based
- Polymer-Based
By Indication:
- General Surgery
- Dental Surgery
- Veterinary Surgery
- Cardiovascular Surgery
- Orthopaedic Surgery
- Others
By End-User:
- Hospitals
- Speciality Clinics
- Veterinary Settings
- Ambulatory Surgical Centers
- Online Sales
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa (MEA)
Frequently Asked Questions
How much is the hemostatic gels market worth in 2021?
The global hemostatic gels market is worth US$ 957.1 Mn in 2021 and is set to expand 2.1X over the next ten years.
What is the sales forecast for the hemostatic gels market through 2032?
The hemostatic gels market is expected to reach US$ 1.9 Bn by the end of 2032, with sales revenue expected to register at 6.8% CAGR.
What are the key trends shaping the hemostatic gels industry?
The growing volume of surgical procedures and the increasing need for hemostatic gels in blood loss management are some of the key trends in this market.
Which are the top 5 countries driving demand for hemostatic gels?
The U.S., the U.K., India, China, and Brazil are expected to drive demand for the hemostatic gels industry.
What is the North American market outlook for hemostatic gels?
North America is one of the key markets for hemostatic gels, with the U.S. accounting for about 82% of the North American hemostatic gels market in the year 2021.
At what percentage is the demand for hemostatic gels expected to register growth in Europe?
Demand for hemostatic gels in Europe is expected to register a growth of 7.1% over the next ten years.
Which countries are the key producers of hemostatic gels?
The U.S., the U.K., India, and China are the key producers of hemostatic gels.
Who are the key players in the hemostatic gels market sphere?
Baxter, Bio-Chem LLC, Clinician's Choice Dental Products Inc., Cresilon, Inc., Dsi Ltd., Endovision Co., Ltd, Ethicon US, LLC, F&A Medical, Prevestdenpro, Septodont, Teleflex Incorporated, Ultradent Products Inc. All, Vladmiva And Medcura, Inc., Are Some Of The Key Players In The Hemostatic Gels Industry.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Development and Innovation Trends 4. Key Success Factors 4.1. Product Adoption / Usage Analysis 4.2. Key Promotional Strategies, By Manufacturers 4.3. Pipeline Assessment 4.4. Value Chain Analysis 4.5. Regulatory Landscape 4.6. PESTEL analysis 4.7. Porter’s analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Outlook 5.1.3. Per Capita Healthcare Expenditure Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Increasing Demand for Targeted Drug Therapies. 5.2.2. Rapidly Increasing volume of surgical procedures 5.2.3. Rising Prevalence of Chronic Disease 5.2.4. Increasing Investments In R&D 5.2.5. Technological Advancements In Hemostatic Agents 5.2.6. Availability Of Technologically Advanced Products 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis – Impact Assessment 6.1. COVID19 and Impact Analysis 6.1.1. Revenue By Material 6.1.2. Revenue By Indication 6.1.3. Revenue By End User 6.1.4. Revenue By Region 6.2. 2021 Market Scenario 7. Global Hemostatic Gels Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032 7.1. Historical Market Value (US$ Mn) Analysis, 2017–2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032, By Material 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Material, 2017–2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Material, 2022–2032 8.3.1. Bovine Based 8.3.2. Porcine Based 8.3.3. Polymer Based 8.4. Market Attractiveness Analysis By Material 9. Global Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032, By Indication 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn), By Indication, 2017–2021 9.3. Current and Future Market Size (US$ Mn) and Forecast By Indication, 2022–2032 9.3.1. General Surgery 9.3.2. Dental Surgery 9.3.3. Veterinary Surgery 9.3.4. Cardiovascular Surgery 9.3.5. Orthopedic Surgery 9.3.6. Others 9.4. Market Attractiveness Analysis By Indication 10. Global Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032, By End-User 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn), By End-User, 2017–2021 10.3. Current and Future Market Size (US$ Mn) and Forecast By End-User, 2022–2032 10.3.1. Hospitals 10.3.2. Speciality Clinics 10.3.3. Veterinary Settings 10.3.4. Ambulatory Surgical Centers 10.3.5. Online Sales 10.4. Market Attractiveness Analysis By End-User 11. Global Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032, by Region 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2021 11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. East Asia 11.3.5. South Asia 11.3.6. Oceania 11.3.7. Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis By Region 12. North America Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032 12.1. Introduction 12.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2017–2021 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032 12.3.1. By Country 12.3.1.1. U.S. 12.3.1.2. Canada 12.3.2. By Material 12.3.3. By Indication 12.3.4. By End-User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Material 12.4.3. By Indication 12.4.4. By End-User 12.5. Key Market Participants - Intensity Mapping 12.6. Drivers and Restraints - Impact Analysis 12.7. Country Level Analysis & Forecast 12.7.1. U.S. Hemostatic Gels Market Analysis 12.7.1.1. .Introduction 12.7.1.2. Market Analysis and Forecast by Market Taxonomy 12.7.1.2.1. By Material 12.7.1.2.2. By Indication 12.7.1.2.3. By End-User 12.7.2. Canada Hemostatic Gels Market Analysis 12.7.2.1. Introduction 12.7.2.2. Market Analysis and Forecast by Market Taxonomy 12.7.2.2.1. By Material 12.7.2.2.2. By Indication 12.7.2.2.3. By End-User 13. Latin America Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032 13.1. Introduction 13.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2017–2021 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032 13.3.1. By Country 13.3.1.1. Mexico 13.3.1.2. Brazil 13.3.1.3. Argentina 13.3.1.4. Rest of Latin America 13.3.2. By Material 13.3.3. By Indication 13.3.4. By End-User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Material 13.4.3. By Indication 13.4.4. By End-User 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 13.7. Country Level Analysis & Forecast 13.7.1. Mexico Hemostatic Gels Market Analysis 13.7.1.1. Introduction 13.7.1.2. Market Analysis and Forecast by Market Taxonomy 13.7.1.2.1. By Material 13.7.1.2.2. By Indication 13.7.1.2.3. By End-User 13.7.2. Brazil Hemostatic Gels Market Analysis 13.7.2.1. Introduction 13.7.2.2. Market Analysis and Forecast by Market Taxonomy 13.7.2.2.1. By Material 13.7.2.2.2. By Indication 13.7.2.2.3. By End-User 13.7.3. Argentina Hemostatic Gels Market Analysis 13.7.3.1. Introduction 13.7.3.2. Market Analysis and Forecast by Market Taxonomy 13.7.3.2.1. By Material 13.7.3.2.2. By Indication 13.7.3.2.3. By End-User 14. Europe Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032 14.1. Introduction 14.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2017–2021 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032 14.3.1. By Country 14.3.1.1. Germany 14.3.1.2. Italy 14.3.1.3. France 14.3.1.4. U.K. 14.3.1.5. Spain 14.3.1.6. Poland 14.3.1.7. Russia 14.3.1.8. Nordic Countries 14.3.1.9. BENULUX 14.3.1.10. Rest of Europe 14.3.2. By Material 14.3.3. By Indication 14.3.4. By End-User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Material 14.4.3. By Indication 14.4.4. By End-User 14.5. Market Trends 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 14.8. Country Level Analysis & Forecast 14.8.1. Germany Hemostatic Gels Market Analysis 14.8.1.1. Introduction 14.8.1.2. Market Analysis and Forecast by Market Taxonomy 14.8.1.2.1. By Material 14.8.1.2.2. By Indication 14.8.1.2.3. By End-User 14.8.2. Italy Hemostatic Gels Market Analysis 14.8.2.1. Introduction 14.8.2.2. Market Analysis and Forecast by Market Taxonomy 14.8.2.2.1. By Material 14.8.2.2.2. By Indication 14.8.2.2.3. By End-User 14.8.3. France Hemostatic Gels Market Analysis 14.8.3.1. Introduction 14.8.3.2. Market Analysis and Forecast by Market Taxonomy 14.8.3.2.1. By Material 14.8.3.2.2. By Indication 14.8.3.2.3. By End-User 14.8.4. U.K. Hemostatic Gels Market Analysis 14.8.4.1. Introduction 14.8.4.2. Market Analysis and Forecast by Market Taxonomy 14.8.4.2.1. By Material 14.8.4.2.2. By Indication 14.8.4.2.3. By End-User 14.8.5. Spain Hemostatic Gels Market Analysis 14.8.5.1. Introduction 14.8.5.2. Market Analysis and Forecast by Market Taxonomy 14.8.5.2.1. By Material 14.8.5.2.2. By Indication 14.8.5.2.3. By End-User 14.8.6. Poland Hemostatic Gels Market Analysis 14.8.6.1. Introduction 14.8.6.2. Market Analysis and Forecast by Market Taxonomy 14.8.6.2.1. By Material 14.8.6.2.2. By Indication 14.8.6.2.3. By End-User 14.8.7. Russia Hemostatic Gels Market Analysis 14.8.7.1. Introduction 14.8.7.2. Market Analysis and Forecast by Market Taxonomy 14.8.7.2.1. By Material 14.8.7.2.2. By Indication 14.8.7.2.3. By End-User 14.8.8. Nordic Countries Hemostatic Gels Market Analysis 14.8.8.1. Introduction 14.8.8.2. Market Analysis and Forecast by Market Taxonomy 14.8.8.2.1. By Material 14.8.8.2.2. By Indication 14.8.8.2.3. By End-User 14.8.9. BENELUX Hemostatic Gels Market Analysis 14.8.9.1. Introduction 14.8.9.2. Market Analysis and Forecast by Market Taxonomy 14.8.9.2.1. By Material 14.8.9.2.2. By Indication 14.8.9.2.3. By End-User 15. South Asia Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032 15.1. Introduction 15.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2017–2021 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Indonesia 15.3.1.3. Malaysia 15.3.1.4. Thailand 15.3.1.5. Rest of South Asia 15.3.2. By Material 15.3.3. By Indication 15.3.4. By End-User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Material 15.4.3. By Indication 15.4.4. By End-User 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 15.7. Country Level Analysis & Forecast 15.7.1. India Hemostatic Gels Market Analysis 15.7.1.1. Introduction 15.7.1.2. Market Analysis and Forecast by Market Taxonomy 15.7.1.2.1. By Material 15.7.1.2.2. By Indication 15.7.1.2.3. By End-User 15.7.2. Indonesia Hemostatic Gels Market Analysis 15.7.2.1. Introduction 15.7.2.2. Market Analysis and Forecast by Market Taxonomy 15.7.2.2.1. By Material 15.7.2.2.2. By Indication 15.7.2.2.3. By End-User 15.7.3. Malaysia Hemostatic Gels Market Analysis 15.7.3.1. Introduction 15.7.3.2. Market Analysis and Forecast by Market Taxonomy 15.7.3.2.1. By Material 15.7.3.2.2. By Indication 15.7.3.2.3. By End-User 15.7.4. Thailand Hemostatic Gels Market Analysis 15.7.4.1. Introduction 15.7.4.2. Market Analysis and Forecast by Market Taxonomy 15.7.4.2.1. By Material 15.7.4.2.2. By Indication 15.7.4.2.3. By End-User 16. East Asia Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032 16.1. Introduction 16.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2017–2021 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032 16.3.1. By Country 16.3.1.1. China 16.3.1.2. Japan 16.3.1.3. South Korea 16.3.2. By By Material 16.3.3. By Indication 16.3.4. By End-User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Material 16.4.3. By Indication 16.4.4. By End-User 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 16.7. Country Level Analysis & Forecast 16.7.1. China Hemostatic Gels Market Analysis 16.7.1.1. Introduction 16.7.1.2. Market Analysis and Forecast by Market Taxonomy 16.7.1.2.1. By Material 16.7.1.2.2. By Indication 16.7.1.2.3. By End-User 16.7.2. Japan Hemostatic Gels Market Analysis 16.7.2.1. Introduction 16.7.2.2. Market Analysis and Forecast by Market Taxonomy 16.7.2.2.1. By Material 16.7.2.2.2. By Indication 16.7.2.2.3. By End-User 16.7.3. South Korea Hemostatic Gels Market Analysis 16.7.3.1. Introduction 16.7.3.2. Market Analysis and Forecast by Market Taxonomy 16.7.3.2.1. By Material 16.7.3.2.2. By Indication 16.7.3.2.3. By End-User 17. Oceania Hemostatic Gels Market 2017-2021 and Forecast 2022-2032 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032 17.3.1. By Country 17.3.1.1. Australia 17.3.1.2. New Zealand 17.3.2. By Material 17.3.3. By Indication 17.3.4. By End-User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Material 17.4.3. By Indication 17.4.4. By End-User 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 17.7. Country Level Analysis & Forecast 17.7.1. Australia Hemostatic Gels Market Analysis 17.7.1.1. Introduction 17.7.1.2. Market Analysis and Forecast by Market Taxonomy 17.7.1.2.1. By Material 17.7.1.2.2. By Indication 17.7.1.2.3. By End-User 17.7.2. New Zealand Hemostatic Gels Market Analysis 17.7.2.1. Introduction 17.7.2.2. Market Analysis and Forecast by Market Taxonomy 17.7.2.2.1. By Material 17.7.2.2.2. By Indication 17.7.2.2.3. By End-User 18. Middle East and Africa (MEA) Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032 18.1. Introduction 18.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2017–2021 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032 18.3.1. By Country 18.3.1.1. Turkey 18.3.1.2. GCC Countries 18.3.1.3. South Africa 18.3.1.4. Rest of Middle East and Africa 18.3.2. By Material 18.3.3. By Indication 18.3.4. By End-User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Material 18.4.3. By Indication 18.4.4. By End-User 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 18.7. Country Level Analysis & Forecast 18.7.1. Turkey Hemostatic Gels Market Analysis 18.7.1.1. Introduction 18.7.1.2. Market Analysis and Forecast by Market Taxonomy 18.7.1.2.1. By Material 18.7.1.2.2. By Indication 18.7.1.2.3. By End-User 18.7.2. GCC Countries Hemostatic Gels Market Analysis 18.7.2.1. Introduction 18.7.2.2. Market Analysis and Forecast by Market Taxonomy 18.7.2.2.1. By Material 18.7.2.2.2. By Indication 18.7.2.2.3. By End-User 18.7.3. South Africa & North Africa Hemostatic Gels Market Analysis 18.7.3.1. Introduction 18.7.3.2. Market Analysis and Forecast by Market Taxonomy 18.7.3.2.1. By Material 18.7.3.2.2. By Indication 18.7.3.2.3. By End-User 19. Market Structure Analysis 19.1. Market Analysis by Tier of Companies 19.2. Market Share Analysis of Top Players 19.3. Company Share Analysis 19.4. Market Presence Analysis 19.4.1. By Regional footprint of Players 19.4.2. Product footprint by Players 19.4.3. Channel Foot Print by Players 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Market Concentration 20.4. Competition Deep Dive (Tentative List) 20.4.1. Baxter 20.4.1.1.1. Overview 20.4.1.1.2. Product Portfolio 20.4.1.1.3. Key Financials 20.4.1.1.4. Sales Footprint 20.4.1.1.5. Strategy Overview 20.4.2. Bio-Chem LLC 20.4.2.1.1. Overview 20.4.2.1.2. Product Portfolio 20.4.2.1.3. Key Financials 20.4.2.1.4. Sales Footprint 20.4.2.1.5. Strategy Overview 20.4.3. Clinician's Choice Dental Products Inc. 20.4.3.1.1. Overview 20.4.3.1.2. Product Portfolio 20.4.3.1.3. Key Financials 20.4.3.1.4. Sales Footprint 20.4.3.1.5. Strategy Overview 20.4.4. Cresilon –VETIGEL 20.4.4.1.1. Overview 20.4.4.1.2. Product Portfolio 20.4.4.1.3. Key Financials 20.4.4.1.4. Sales Footprint 20.4.4.1.5. Strategy Overview 20.4.5. DSI Ltd. 20.4.5.1.1. Overview 20.4.5.1.2. Product Portfolio 20.4.5.1.3. Key Financials 20.4.5.1.4. Sales Footprint 20.4.5.1.5. Strategy Overview 20.4.6. ENDOVISION CO.,LTD 20.4.6.1.1. Overview 20.4.6.1.2. Product Portfolio 20.4.6.1.3. Key Financials 20.4.6.1.4. Sales Footprint 20.4.6.1.5. Strategy Overview 20.4.7. Ethicon US, LLC 20.4.7.1.1. Overview 20.4.7.1.2. Product Portfolio 20.4.7.1.3. Key Financials 20.4.7.1.4. Sales Footprint 20.4.7.1.5. Strategy Overview 20.4.8. F&A Medical 20.4.8.1.1. Overview 20.4.8.1.2. Product Portfolio 20.4.8.1.3. Key Financials 20.4.8.1.4. Sales Footprint 20.4.8.1.5. Strategy Overview 20.4.9. PrevestDenPro 20.4.9.1.1. Overview 20.4.9.1.2. Product Portfolio 20.4.9.1.3. Key Financials 20.4.9.1.4. Sales Footprint 20.4.9.1.5. Strategy Overview 20.4.10. Septodont 20.4.10.1.1. Overview 20.4.10.1.2. Product Portfolio 20.4.10.1.3. Key Financials 20.4.10.1.4. Sales Footprint 20.4.10.1.5. Strategy Overview 20.4.11. Teleflex Incorporated 20.4.11.1.1. Overview 20.4.11.1.2. Product Portfolio 20.4.11.1.3. Key Financials 20.4.11.1.4. Sales Footprint 20.4.11.1.5. Strategy Overview 20.4.12. Ultradent Products Inc. All 20.4.12.1.1. Overview 20.4.12.1.2. Product Portfolio 20.4.12.1.3. Key Financials 20.4.12.1.4. Sales Footprint 20.4.12.1.5. Strategy Overview 20.4.13. VladMiVa 20.4.13.1.1. Overview 20.4.13.1.2. Product Portfolio 20.4.13.1.3. Key Financials 20.4.13.1.4. Sales Footprint 20.4.13.1.5. Strategy Overview 20.4.14. Medcura, Inc., 20.4.14.1.1. Overview 20.4.14.1.2. Product Portfolio 20.4.14.1.3. Key Financials 20.4.14.1.4. Sales Footprint 20.4.14.1.5. Strategy Overview 21. Assumptions and Acronyms Used 22. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material Table 02: Global Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material Table 03: Global Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication Table 04: Global Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication Table 05: Global Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User Table 06: Global Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User Table 07: Global Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Region Table 08: Global Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Region Table 09: North America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country Table 10: North America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country Table 11: North America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material Table 12: North America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material Table 13: North America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication Table 14: North America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication Table 15: North America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User Table 16: North America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User Table 17: Latin America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country Table 18: Latin America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country Table 19: Latin America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material Table 20: Latin America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material Table 21: Latin America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication Table 22: Latin America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication Table 23: Latin America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User Table 24: Latin America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User Table 25: Europe Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country Table 26: Europe Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country Table 27: Europe Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material Table 28: Europe Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material Table 29: Europe Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication Table 30: Europe Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication Table 31: Europe Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User Table 32: Europe Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User Table 33: South Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country Table 34: South Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country Table 35: South Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material Table 36: South Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material Table 37: South Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication Table 38: South Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication Table 39: South Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User Table 40: South Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User Table 41: East Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country Table 42: East Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country Table 43: East Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material Table 44: East Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material Table 45: East Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication Table 46: East Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication Table 47: East Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User Table 48: East Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User Table 49: Oceania Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country Table 50: Oceania Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country Table 51: Oceania Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material Table 52: Oceania Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material Table 53: Oceania Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication Table 54: Oceania Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication Table 55: Oceania Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User Table 56: Oceania Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User Table 57: Middle East and Africa Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country Table 58: Middle East and Africa Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country Table 59: Middle East and Africa (MEA) Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material Table 60: Middle East and Africa (MEA) Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material Table 61: Middle East and Africa (MEA) Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication Table 62: Middle East and Africa (MEA) Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication Table 63: Middle East and Africa (MEA) Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User Table 64: Middle East and Africa (MEA) Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021 Figure 02: Global Hemostatic Gels Market Value (US$ Mn), 2022 – 2032 & Y-o-Y Growth Trend Analysis Figure 03: Global Hemostatic Gels Market Absolute $ Opportunity, 2022-2032 Figure 04: Global Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 05: Global Hemostatic Gels Market Y-o-Y Analysis (%), By Material, 2022-2032 Figure 06: Global Hemostatic Gels Market Attractiveness Analysis By Material, 2022-2032 Figure 07: Global Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 08: Global Hemostatic Gels Market Y-o-Y Analysis (%), By Indication, 2022-2032 Figure 09: Global Hemostatic Gels Market Attractiveness Analysis By Indication, 2022-2032 Figure 10: Global Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 11: Global Hemostatic Gels Market Y-o-Y Analysis (%), By End User, 2022-2032 Figure 12: Global Hemostatic Gels Market Attractiveness Analysis by End User, 2022-2032 Figure 13: Global Hemostatic Gels Market Share Analysis (%), By Region, 2021 & 2032 Figure 14: Global Hemostatic Gels Market Y-o-Y Analysis (%), By Region, 2022-2032 Figure 15: Global Hemostatic Gels Market Attractiveness Analysis by Region, 2022-2032 Figure 16: North America Hemostatic Gels Market Share Analysis (%), By Country (2022) Figure 17: North America Hemostatic Gels Market Share Analysis (%), By Material (2022) Figure 18: North America Hemostatic Gels Market Share Analysis (%), By Indication (2022) Figure 19: North America Hemostatic Gels Market Share Analysis (%), By End User (2022) Figure 20: North America Hemostatic Gels Market Value (US$ Mn) Analysis, 2017–2021 Figure 21: North America Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis Figure 22: North America Hemostatic Gels Market Attractiveness Analysis, By Country Figure 23: North America Hemostatic Gels Market Attractiveness Analysis, By Material Figure 24: North America Hemostatic Gels Market Attractiveness Analysis, By Indication Figure 25: North America Hemostatic Gels Market Attractiveness Analysis, By End User Figure 26: U.S. Market Value Proportion Analysis, 2021 Figure 27: Global Vs U.S. Y-o-Y Growth Comparison, 2021-2032 Figure 28: U.S. Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 29: U.S. Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 30: U.S. Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 31: Canada Market Value Proportion Analysis, 2021 Figure 32: Global Vs Canada Y-o-Y Growth Comparison, 2021-2032 Figure 33: Canada Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 34: Canada Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 35: Canada Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 36: Latin America Hemostatic Gels Market Share Analysis (%), By Country (2022) Figure 37: Latin America Hemostatic Gels Market Share Analysis (%), By Material (2022) Figure 38: Latin America Hemostatic Gels Market Share Analysis (%), By Indication (2022) Figure 39: Latin America Hemostatic Gels Market Share Analysis (%), By End User (2022) Figure 40: Latin America Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021 Figure 41: Latin America Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis Figure 42: Latin America Hemostatic Gels Market Attractiveness Analysis, By Country Figure 43: Latin America Hemostatic Gels Market Attractiveness Analysis, By Material Figure 44: Latin America Hemostatic Gels Market Market Attractiveness Analysis, By Indication Figure 45: Latin America Hemostatic Gels Market Attractiveness Analysis, By End User Figure 46: Brazil Market Value Proportion Analysis, 2021 Figure 47: Global Vs Brazil Y-o-Y Growth Comparison, 2021-2032 Figure 48: Brazil Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 49: Brazil Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 50: Brazil Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 51: Mexico Market Value Proportion Analysis, 2021 Figure 52: Global Vs Mexico Y-o-Y Growth Comparison, 2021-2032 Figure 53: Mexico Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 54: Mexico Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 55: Mexico Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 56: Argentina Market Value Proportion Analysis, 2021 Figure 57: Global Vs Argentina Y-o-Y Growth Comparison, 2021-2032 Figure 58: Argentina Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 59: Argentina Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 60: Argentina Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 61: Europe Hemostatic Gels Market Share Analysis (%), By Country (2022) Figure 62: Europe Hemostatic Gels Market Share Analysis (%), By Material (2022) Figure 63: Europe Hemostatic Gels Market Share Analysis (%), By Indication (2022) Figure 64: Europe Hemostatic Gels Market Share Analysis (%), By End User (2022) Figure 65: Europe Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021 Figure 66: Europe Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis Figure 67: Europe Hemostatic Gels Market Market Attractiveness Analysis, By Country Figure 68: Europe Hemostatic Gels Market Attractiveness Analysis, By Material Figure 69: Europe Hemostatic Gels Market Market Attractiveness Analysis, By Indication Figure 70: Europe Hemostatic Gels Market Attractiveness Analysis, By End User Figure 71: Germany Market Value Proportion Analysis, 2021 Figure 72: Global Vs Germany Y-o-Y Growth Comparison, 2021-2032 Figure 73: Germany Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 74: Germany Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 75: Germany Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 76: Italy Market Value Proportion Analysis, 2021 Figure 77: Global Vs Italy Y-o-Y Growth Comparison, 2021-2032 Figure 78: Italy Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 79: Italy Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 80: Italy Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 81: France Market Value Proportion Analysis, 2021 Figure 82: Global Vs France Y-o-Y Growth Comparison, 2021-2032 Figure 83: France Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 84: France Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 85: France Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 86: U.K. Market Value Proportion Analysis, 2021 Figure 87: Global Vs U.K. Y-o-Y Growth Comparison, 2021-2032 Figure 88: U.K. Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 89: U.K. Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 90: U.K. Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 91: Spain Market Value Proportion Analysis, 2021 Figure 92: Global Vs Spain Y-o-Y Growth Comparison, 2021-2032 Figure 93: Spain Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 94: Spain Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 95: Spain Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 96: BENELUX Market Value Proportion Analysis, 2021 Figure 97: Global Vs BENELUX Y-o-Y Growth Comparison, 2021-2032 Figure 98: BENELUX Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 99: BENELUX Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 100: BENELUX Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 101: Russia Market Value Proportion Analysis, 2021 Figure 102: Global Vs Russia Y-o-Y Growth Comparison, 2021-2032 Figure 103: Russia Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 104: Russia Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 105: Russia Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 106: South Asia Hemostatic Gels Market Share Analysis (%), By Country (2022) Figure 107: South Asia Hemostatic Gels Market Share Analysis (%), By Material (2022) Figure 108: South Asia Hemostatic Gels Market Share Analysis (%), By Indication (2022) Figure 109: South Asia Hemostatic Gels Market Share Analysis (%), By End User (2022) Figure 110: South Asia Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021 Figure 111: South Asia Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis Figure 112: South Asia Hemostatic Gels Market Market Attractiveness Analysis, By Country Figure 113: South Asia Hemostatic Gels Market Attractiveness Analysis, By Material Figure 114: South Asia Hemostatic Gels Market Market Attractiveness Analysis, By Indication Figure 115: South Asia Hemostatic Gels Market Attractiveness Analysis, By End User Figure 116: India Market Value Proportion Analysis, 2021 Figure 117: Global Vs India Y-o-Y Growth Comparison, 2021-2032 Figure 118: India Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 119: India Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 120: India Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 121: Thailand Market Value Proportion Analysis, 2021 Figure 122: Global Vs Thailand Y-o-Y Growth Comparison, 2021-2032 Figure 123: Thailand Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 124: Thailand Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 125: Thailand Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 126: Indonesia Market Value Proportion Analysis, 2021 Figure 127: Global Vs Indonesia Y-o-Y Growth Comparison, 2021-2032 Figure 128: Indonesia Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 129: Indonesia Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 130: Indonesia Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 131: Malaysia Market Value Proportion Analysis, 2021 Figure 132: Global Vs Malaysia Y-o-Y Growth Comparison, 2021-2032 Figure 133: Malaysia Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 134: Malaysia Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 135: Malaysia Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 136: East Asia Hemostatic Gels Market Share Analysis (%), By Country (2022) Figure 137: East Asia Hemostatic Gels Market Share Analysis (%), By Material (2022) Figure 138: East Asia Hemostatic Gels Market Share Analysis (%), By Indication (2022) Figure 139: East Asia Hemostatic Gels Market Share Analysis (%), By End User (2022) Figure 140: East Asia Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021 Figure 141: East Asia Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis Figure 142: East Asia Hemostatic Gels Market Market Attractiveness Analysis, By Country Figure 143: East Asia Hemostatic Gels Market Attractiveness Analysis, By Material Figure 144: East Asia Hemostatic Gels Market Market Attractiveness Analysis, By Indication Figure 145: East Asia Hemostatic Gels Market Attractiveness Analysis, By End User Figure 146: China Market Value Proportion Analysis, 2021 Figure 147: Global Vs China Y-o-Y Growth Comparison, 2021-2032 Figure 148: China Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 149: China Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 150: China Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 151: Japan Market Value Proportion Analysis, 2021 Figure 152: Global Vs Japan Y-o-Y Growth Comparison, 2021-2032 Figure 153: Japan Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 154: Japan Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 155: Japan Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 156: South Korea Market Value Proportion Analysis, 2021 Figure 157: Global Vs South Korea Y-o-Y Growth Comparison, 2021-2032 Figure 158: South Korea Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 159: South Korea Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 160: South Korea Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 161: Oceania Hemostatic Gels Market Share Analysis (%), By Country (2022) Figure 162: Oceania Hemostatic Gels Market Share Analysis (%), By Material (2022) Figure 163: Oceania Hemostatic Gels Market Share Analysis (%), By Indication (2022) Figure 164: Oceania Hemostatic Gels Market Share Analysis (%), By End User (2022) Figure 165: Oceania Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021 Figure 166: Oceania Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis Figure 167: Oceania Hemostatic Gels Market Attractiveness Analysis, By Country Figure 168: Oceania Hemostatic Gels Market Attractiveness Analysis, By Material Figure 169: Oceania Hemostatic Gels Market Attractiveness Analysis, By Indication Figure 170: Oceania Hemostatic Gels Market Attractiveness Analysis, By End User Figure 171: Australia Market Value Proportion Analysis, 2021 Figure 172: Global Vs Australia Y-o-Y Growth Comparison, 2021-2032 Figure 173: Australia Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 174: Australia Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 175: Australia Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 176: New Zealand Market Value Proportion Analysis, 2021 Figure 177: Global Vs New Zealand Y-o-Y Growth Comparison, 2021-2032 Figure 178: New Zealand Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 179: New Zealand Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 180: New Zealand Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 181: Middle East and Africa (MEA) Hemostatic Gels Market Share Analysis (%), By Country (2022) Figure 182: Middle East and Africa (MEA) Hemostatic Gels Market Share Analysis (%), By Material (2022) Figure 183: Middle East and Africa (MEA) Hemostatic Gels Market Share Analysis (%), By Indication (2022) Figure 184: Middle East and Africa (MEA) Hemostatic Gels Market Share Analysis (%), By End User (2022) Figure 185: Middle East and Africa (MEA) Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021 Figure 186: Middle East and Africa (MEA) Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis Figure 187: Middle East and Africa (MEA) Hemostatic Gels Market Attractiveness Analysis, By Country Figure 188: Middle East and Africa (MEA) Hemostatic Gels Market Attractiveness Analysis, By Material Figure 189: Middle East and Africa (MEA) Hemostatic Gels Market Attractiveness Analysis, By Indication Figure 190: Middle East and Africa (MEA) Hemostatic Gels Market Attractiveness Analysis, By End User Figure 191: GCC Countries Market Value Proportion Analysis, 2021 Figure 192: Global Vs GCC Countries Y-o-Y Growth Comparison, 2021-2032 Figure 193: GCC Countries Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 194: GCC Countries Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 195: GCC Countries Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 196: Turkey Market Value Proportion Analysis, 2021 Figure 197: Global Vs Turkey Y-o-Y Growth Comparison, 2021-2032 Figure 198: Turkey Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 199: Turkey Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 200: Turkey Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 201: North Africa Market Value Proportion Analysis, 2021 Figure 202: Global Vs North Africa Y-o-Y Growth Comparison, 2021-2032 Figure 203: North Africa Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 204: North Africa Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 205: North Africa Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032 Figure 206: South Africa Market Value Proportion Analysis, 2021 Figure 207: Global Vs South Africa Y-o-Y Growth Comparison, 2021-2032 Figure 208: South Africa Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032 Figure 209: South Africa Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032 Figure 210: South Africa Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
